Fintel reports that on April 15, 2025, Baird downgraded their outlook for Elevance Health (NYSE:ELV) from Outperform to ...

Elevance Health (NYSE:ELV) has been analyzed by 5 analysts in the last three months, revealing a diverse range of perspectives from bullish to bearish. In the table below, you'll find a summary of ...

For full-year 2024, Elevance reported $175.2 billion in revenue, an increase of 2.9% over its $170.2 billion haul in 2023.

Elevance continues to expect its Medicare Advantage program to hit 2.2 million to 2.25 million members in 2025, and for adjusted earnings to be $34.15 to $34.85 a share.

In a regulatory filing, Elevance Health (ELV) noted it will release its first quarter 2025 financial results on April 22. “First quarter ...

In this article, we are going to take a look at where Elevance Health, Inc. (NYSE:ELV) stands against other best medical stocks to buy according to billionaires. Some experts view medical ...

Elevance Health Stock Up 0.3 % Elevance Health stock opened at $441.02 on Tuesday. The stock has a 50 day moving average of $413.71 and a two-hundred day moving average of $411.99. Elevance Health ...

In a regulatory filing, Elevance Health (ELV) noted it will release its first quarter 2025 financial results on April 22. The company expects ...